122 related articles for article (PubMed ID: 34247064)
1. Sexual identity differences in biomarkers of tobacco exposure among women in a national sample.
Evans-Polce RJ; Smith DM; Veliz P; Boyd CJ; McCabe SE
Cancer Epidemiol; 2021 Oct; 74():101980. PubMed ID: 34247064
[TBL] [Abstract][Full Text] [Related]
2. Biomarkers of Exposure among U.S. Adult Cigar Smokers: Population Assessment of Tobacco and Health (PATH) Study Wave 1 (2013-2014).
Chang CM; Rostron BL; Chang JT; Corey CG; Kimmel HL; Sosnoff CS; Goniewicz ML; Edwards KC; Hatsukami DK; Wang Y; Del Valle-Pinero AY; Yang M; Travers MJ; Arnstein S; Taylor K; Conway K; Ambrose BK; Borek N; Hyland A; Wang L; Blount BC; van Bemmel DM
Cancer Epidemiol Biomarkers Prev; 2019 May; 28(5):943-953. PubMed ID: 30733305
[TBL] [Abstract][Full Text] [Related]
3. Nicotine and Toxicant Exposure among U.S. Smokeless Tobacco Users: Results from 1999 to 2012 National Health and Nutrition Examination Survey Data.
Rostron BL; Chang CM; van Bemmel DM; Xia Y; Blount BC
Cancer Epidemiol Biomarkers Prev; 2015 Dec; 24(12):1829-37. PubMed ID: 26582044
[TBL] [Abstract][Full Text] [Related]
4. Investigation of exposure biomarkers in human plasma following differing levels of tobacco-specific N-nitrosamines and nicotine in cigarette smoke.
Zhang J; Liu X; Shi B; Yang Z; Luo Y; Xu T; Liu D; Jiang C; Du G; Lu N; Zhang C; Ma Y; Bai R; Zhou J
Environ Res; 2022 Nov; 214(Pt 2):113811. PubMed ID: 35835167
[TBL] [Abstract][Full Text] [Related]
5. Validation of the Wave 1 and Wave 2 Population Assessment of Tobacco and Health (PATH) Study Indicators of Tobacco Dependence Using Biomarkers of Nicotine Exposure Across Tobacco Products.
Strong DR; Leas E; Noble M; White M; Glasser A; Taylor K; Edwards KC; Frissell KC; Compton WM; Conway KP; Lambert E; Kimmel HL; Silveira ML; Hull LC; van Bemmel D; Schroeder MJ; Cummings KM; Hyland A; Feng J; Blount B; Wang L; Niaura R
Nicotine Tob Res; 2022 Jan; 24(1):10-19. PubMed ID: 34383052
[TBL] [Abstract][Full Text] [Related]
6. Exposure to Nicotine and Toxicants Among Dual Users of Tobacco Cigarettes and E-Cigarettes: Population Assessment of Tobacco and Health (PATH) Study, 2013-2014.
Smith DM; Christensen C; van Bemmel D; Borek N; Ambrose B; Erives G; Niaura R; Edwards KC; Stanton CA; Blount BC; Wang L; Feng J; Jarrett JM; Ward CD; Hatsukami D; Hecht SS; Kimmel HL; Travers M; Hyland A; Goniewicz ML
Nicotine Tob Res; 2021 May; 23(5):790-797. PubMed ID: 33590857
[TBL] [Abstract][Full Text] [Related]
7. Biomarkers of Exposure among USA Adult Hookah Users: Results from Wave 1 of the Population Assessment of Tobacco and Health (PATH) Study (2013-2014).
Travers MJ; Rivard C; Sharma E; Retzky S; Yucesoy B; Goniewicz ML; Stanton CA; Chen J; Callahan-Lyon P; Kimmel HL; Xia B; Wang Y; Sosnoff CS; De Jesús VR; Blount BC; Hecht SS; Hyland A
Int J Environ Res Public Health; 2020 Sep; 17(17):. PubMed ID: 32887496
[TBL] [Abstract][Full Text] [Related]
8. Urinary Nicotine Metabolites and Self-Reported Tobacco Use Among Adults in the Population Assessment of Tobacco and Health (PATH) Study, 2013-2014.
Feng J; Sosnoff CS; Bernert JT; Blount BC; Li Y; Del Valle-Pinero AY; Kimmel HL; van Bemmel DM; Rutt SM; Crespo-Barreto J; Borek N; Edwards KC; Alexander R; Arnstein S; Lawrence C; Hyland A; Goniewicz ML; Rehmani I; Pine B; Pagnotti V; Wade E; Sandlin J; Luo Z; Piyankarage S; Hatsukami DK; Hecht SS; Conway KP; Wang L
Nicotine Tob Res; 2022 Mar; 24(5):768-777. PubMed ID: 35348786
[TBL] [Abstract][Full Text] [Related]
9. Cluster analysis of urinary tobacco biomarkers among U.S. adults: Population Assessment of Tobacco and Health (PATH) biomarker study (2013-2014).
Majeed B; Linder D; Eissenberg T; Tarasenko Y; Smith D; Ashley D
Prev Med; 2020 Nov; 140():106218. PubMed ID: 32693174
[TBL] [Abstract][Full Text] [Related]
10. Disparities in the frequency of tobacco products use by sexual identity status.
Azagba S; Shan L
Addict Behav; 2021 Nov; 122():107032. PubMed ID: 34229134
[TBL] [Abstract][Full Text] [Related]
11. Assessment of passive human exposure to tobacco smoke by environmental and biological monitoring in different public places in Wuhan, central China.
Zhong Q; Li Y; Mei X; Li J; Huang Y
Int J Hyg Environ Health; 2022 Jul; 244():114008. PubMed ID: 35870316
[TBL] [Abstract][Full Text] [Related]
12. Comparison of Nicotine and Toxicant Exposure in Users of Electronic Cigarettes and Combustible Cigarettes.
Goniewicz ML; Smith DM; Edwards KC; Blount BC; Caldwell KL; Feng J; Wang L; Christensen C; Ambrose B; Borek N; van Bemmel D; Konkel K; Erives G; Stanton CA; Lambert E; Kimmel HL; Hatsukami D; Hecht SS; Niaura RS; Travers M; Lawrence C; Hyland AJ
JAMA Netw Open; 2018 Dec; 1(8):e185937. PubMed ID: 30646298
[TBL] [Abstract][Full Text] [Related]
13. Inequities in tobacco advertising exposure among young adult sexual, racial and ethnic minorities: examining intersectionality of sexual orientation with race and ethnicity.
Tan ASL; Hanby EP; Sanders-Jackson A; Lee S; Viswanath K; Potter J
Tob Control; 2021 Jan; 30(1):84-93. PubMed ID: 31857490
[TBL] [Abstract][Full Text] [Related]
14. Urinary Cotinine and Cotinine + Trans-3'-Hydroxycotinine (TNE-2) Cut-points for Distinguishing Tobacco Use from Nonuse in the United States: PATH Study (2013-2014).
Edwards KC; Naz T; Stanton CA; Goniewicz ML; Hatsukami DK; Smith DM; Wang L; Villanti A; Pearson J; Blount BC; Bansal-Travers M; Feng J; Niaura R; Manderski MTB; Sosnoff CS; Delnevo CD; Duffy K; Del Valle-Pinero AY; Rostron BL; Everard C; Kimmel HL; van Bemmel DM; Hyland A
Cancer Epidemiol Biomarkers Prev; 2021 Jun; 30(6):1175-1184. PubMed ID: 33827982
[TBL] [Abstract][Full Text] [Related]
15. Nicotine Exposure in the U.S. Population: Total Urinary Nicotine Biomarkers in NHANES 2015-2016.
Mazumder S; Shia W; Bendik PB; Achilihu H; Sosnoff CS; Alexander JR; Luo Z; Zhu W; Pine BN; Feng J; Blount BC; Wang L
Int J Environ Res Public Health; 2022 Mar; 19(6):. PubMed ID: 35329347
[TBL] [Abstract][Full Text] [Related]
16. Exposure to Toxicants Associated With Use and Transitions Between Cigarettes, e-Cigarettes, and No Tobacco.
Dai H; Benowitz NL; Achutan C; Farazi PA; Degarege A; Khan AS
JAMA Netw Open; 2022 Feb; 5(2):e2147891. PubMed ID: 35142830
[TBL] [Abstract][Full Text] [Related]
17. Urine 4-(methylnitrosamino)-1-(3) pyridyl-1-butanol and cotinine in Alaska native postpartum women and neonates comparing smokers and smokeless tobacco users.
Benowitz NL; Flanagan CA; Thomas TK; Koller KR; Wolfe AW; Renner CC; Hughes C; Decker PA; Hatsukami DK; Murphy NJ; Patten C
Int J Circumpolar Health; 2018 Dec; 77(1):1528125. PubMed ID: 30325719
[TBL] [Abstract][Full Text] [Related]
18. Validating Wave 1 (2014) Urinary Cotinine and TNE-2 Cut-points for Differentiating Wave 4 (2017) Cigarette Use from Non-use in the United States Using Data from the PATH Study.
Edwards KC; Khan A; Sharma E; Wang L; Feng J; Blount BC; Sosnoff CS; Smith DM; Goniewicz ML; Pearson J; Villanti AC; Delnevo CD; Bover-Manderski MT; Hatsukami DK; Niaura R; Everard C; Kimmel HL; Duffy K; Rostron BL; Del Valle-Pinero AY; van Bemmel DM; Stanton CA; Hyland A
Cancer Epidemiol Biomarkers Prev; 2023 Sep; 32(9):1233-1241. PubMed ID: 37342065
[TBL] [Abstract][Full Text] [Related]
19. Tobacco product use and susceptibility to use among sexual minority and heterosexual adolescents.
Garcia LC; Vogel EA; Prochaska JJ
Prev Med; 2021 Apr; 145():106384. PubMed ID: 33359018
[TBL] [Abstract][Full Text] [Related]
20. Tobacco Product Use Patterns, and Nicotine and Tobacco-Specific Nitrosamine Exposure: NHANES 1999-2012.
Choi K; Sabado M; El-Toukhy S; Vogtmann E; Freedman ND; Hatsukami D
Cancer Epidemiol Biomarkers Prev; 2017 Oct; 26(10):1525-1530. PubMed ID: 28710077
[No Abstract] [Full Text] [Related]
[Next] [New Search]
